Tina Bhutani, MD: Assessing the Quality of Life Impact in Patients with Generalized Pustular Psoriasis
Dr. Bhutani discusses how the inconvenience of frequent hospitalizations caused by flare ups can diminish a patient’s quality of life.
Tina Bhutani, MD: Diagnosing Patients with Generalized Pustular Psoriasis
Dr. Bhutani describes the unpredictable nature of generalized pustular psoriasis and the downstream comorbidities that can occur if a patient remains untreated.
Alice Gottlieb, MD, PhD: Previewing the 2025 Masterclasses in Dermatology Meeting
Dr. Gottlieb discusses the upcoming sessions and featured topics being presented at the Masterclasses in Dermatology meeting in Sarasota, Florida.
Lisa Swanson, MD: Insights on Maximum-use of Ruxolitinib Cream in Pediatric Patients with Atopic Dermatitis
Lisa Swanson, MD, JCAD’s Section Editor of Pediatric Dermatology, shares her thoughts on new research evaluating maximum-use conditions for topical ruxolitinib cream in pediatric patients (2 to 11 years) with atopic dermatitis.
Lisa Swanson, MD: Insights on Maximum-use of Ruxolitinib Cream in Pediatric Patients with Atopic Dermatitis
Lisa Swanson, MD, JCAD’s Section Editor of Pediatric Dermatology, shares her thoughts on new research evaluating maximum-use conditions for topical ruxolitinib cream in pediatric patients (2 to 11 years) with atopic dermatitis. Reference: